Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2025-12-25 @ 8:34 PM
NCT ID:
NCT02919969
Group ID:
EG000
Title:
Pembrolizumab
Description:
Pembrolizumab is administered every 3 week intravenously. Dosage to be determined by physician
Pembrolizumab: Pembrolizumab 200 mg will be administered as a 30 minute IV infusion every 3 weeks.
Deaths Number Affected:
24
Deaths Number At Risk:
None
Serious Number Affected:
13
Serious Number At Risk:
32
Other Number Affected:
24
Other Number At Risk:
32
Study:
NCT02919969
Results Section:
NCT02919969
Adverse Events Module:
NCT02919969